Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Asset Utilization Ratio (2019 - 2025)

Arcturus Therapeutics Holdings' Asset Utilization Ratio history spans 7 years, with the latest figure at 0.3 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 30.45% year-over-year to 0.3; the TTM value through Dec 2025 reached 0.3, down 30.45%, while the annual FY2025 figure was 0.27, 32.29% down from the prior year.
  • Asset Utilization Ratio reached 0.3 in Q4 2025 per ARCT's latest filing, down from 0.33 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.67 in Q3 2023 to a low of 0.02 in Q2 2021.
  • Average Asset Utilization Ratio over 5 years is 0.31, with a median of 0.35 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: plummeted 92.39% in 2021, then skyrocketed 1753.49% in 2022.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.03 in 2021, then skyrocketed by 1753.49% to 0.55 in 2022, then plummeted by 32.09% to 0.38 in 2023, then rose by 13.33% to 0.43 in 2024, then crashed by 30.45% to 0.3 in 2025.
  • Per Business Quant, the three most recent readings for ARCT's Asset Utilization Ratio are 0.3 (Q4 2025), 0.33 (Q3 2025), and 0.38 (Q2 2025).